5
1
Pharmacy Practice and the Law
400
by Richard R. Abood, Kimberly A. Burns, Frederick Frankhauser
Richard R. Abood
Pharmacy Practice and the Law
400
by Richard R. Abood, Kimberly A. Burns, Frederick Frankhauser
Richard R. Abood
Paperback(10th ed.)
$152.95
-
PICK UP IN STORECheck Availability at Nearby Stores
Available within 2 business hours
Related collections and offers
152.95
In Stock
Overview
Pharmacy Practice and the Law, Tenth Edition not only helps students prepare for their upcoming board exam, but also urges them to understand and critically analyze the law that governs both the profession and the products they distribute. With the most up-to-date federal, legal, regulatory, and policy developments, as well as new developments to various medical and pharmaceutical programs, the Tenth Edition provides a comprehensive overview with an accessible, student-friendly writing style.
Product Details
ISBN-13: | 9781284280135 |
---|---|
Publisher: | Jones & Bartlett Learning |
Publication date: | 11/02/2023 |
Edition description: | 10th ed. |
Pages: | 400 |
Sales rank: | 630,871 |
Product dimensions: | 8.53(w) x 10.88(h) x 0.74(d) |
About the Author
Richard Abood received a B.S. in Pharmacy from the University of Nebraska in Lincoln and a Juris Doctorate degree from the same institution. He has worked in both community and hospital pharmacy practice. He holds the title of Professor Emeritus in Pharmacy Practice at the University of the Pacific where he was Professor of Pharmacy Practice for 23 years. Previously he was Professor of Pharmacy Administration at the University of Wyoming and concurrently served for several years as the Executive Director and legal counsel for the Wyoming Pharmaceutical Association. Professor Abood has given numerous presentations and authored several publications in the areas of pharmacy and health care law.In 2000 the American Society for Pharmacy Law presented him the President’s Award for his cumulative achievements in pharmacy law. In 2002 the University of the Pacific awarded him the Eberhardt Teacher/Scholar Award, Pacific’s highest honor for excellence in combined teaching and scholarship. In 2013 Pacific presented him the Order of the Pacific, its highest honor for a career of distinguished teaching, scholarship, and service. Professor Abood has been active in several state and national pharmacy organizations. He has served as president and board member of the San Joaquin Pharmacists Association; and as president and board member of the American Society for Pharmacy Law. Professor Abood has regularly served as a consultant on pharmacy law issues to law firms, state and federal governments, and pharmacy organizations.
Kimberly Burns is a Professor at the Lake Erie College of Osteopathic Medicine (LECOM) School of Pharmacy, located in Erie, PA.She received her B.S. in Pharmacy from the University of Pittsburgh School of Pharmacy (cum laude) and her Juris Doctor degree from Duquesne University Law School (cum laude).She is both a licensed pharmacist and attorney in Pennsylvania. Kim has been a professor at the LECOM School of Pharmacy since 2002.Her teaching responsibilities include Pharmacy Law and Ethics and an elective advanced practice rotation site at the Erie County Department of Health, where she primarily contributes to local prescription drug abuse efforts.In addition to her academic career, she practiced community pharmacy for over 15 years and has consulted on various legal cases regarding pharmacy law issues. She has also written a number of papers and commentaries, and has made presentations at the local, state, and national level on a variety of pharmacy law topics. Professor Burns has been active in several state and national pharmacy organizations, including the American Society of Pharmacy Law where she served as board member and president.Professor Burns has also been recognized with various awards for her leadership and contributions to community service, research, and teaching.
Kimberly Burns is a Professor at the Lake Erie College of Osteopathic Medicine (LECOM) School of Pharmacy, located in Erie, PA.She received her B.S. in Pharmacy from the University of Pittsburgh School of Pharmacy (cum laude) and her Juris Doctor degree from Duquesne University Law School (cum laude).She is both a licensed pharmacist and attorney in Pennsylvania. Kim has been a professor at the LECOM School of Pharmacy since 2002.Her teaching responsibilities include Pharmacy Law and Ethics and an elective advanced practice rotation site at the Erie County Department of Health, where she primarily contributes to local prescription drug abuse efforts.In addition to her academic career, she practiced community pharmacy for over 15 years and has consulted on various legal cases regarding pharmacy law issues. She has also written a number of papers and commentaries, and has made presentations at the local, state, and national level on a variety of pharmacy law topics. Professor Burns has been active in several state and national pharmacy organizations, including the American Society of Pharmacy Law where she served as board member and president.Professor Burns has also been recognized with various awards for her leadership and contributions to community service, research, and teaching.
Table of Contents
Preface | ix | |
Chapter 1 | The Law and The Legal System | 1 |
Chapter Objectives | 1 | |
Nature and Role of Law | 2 | |
Sources of U.S. Law | 5 | |
The Legislative Process | 10 | |
Distinguishing Criminal, Civil, and Administrative Law | 12 | |
The Judicial Process | 12 | |
Federal Verses State Law | 19 | |
Case Studies | 21 | |
Chapter 2 | Federal Regulation of Medications: Development, Production, and Marketing | 37 |
Chapter Objectives | 37 | |
Historical Overview of the Federal Food, Drug, and Cosmetic Act | 38 | |
Defining and Distinguishing Drugs from Foods, Devices, and Cosmetics | 42 | |
Prohibited Acts, Penalties, and Enforcement | 51 | |
Adulterated Drugs | 54 | |
Misbranded Drugs | 56 | |
New Drug Approval | 63 | |
Generic Drugs as New Drugs | 68 | |
Drugs Intended to Treat Serious and Life-Threatening Diseases | 71 | |
Voluntary Reporting Programs | 72 | |
Medical Device Act (Amendments) of 1976 | 73 | |
Cosmetics | 74 | |
Drug Advertising and Promotion | 75 | |
Case Studies | 83 | |
Chapter 3 | Federal Regulation of Medications: Dispensing | 101 |
Chapter Objectives | 101 | |
Durham-Humphrey Amendment | 102 | |
Approved Drugs for Unlabeled Indications | 111 | |
Pharmacy Compounding Versus Manufacturing | 112 | |
The Orange Book | 116 | |
Prescription Drug Marketing Act of 1987 | 119 | |
Inspections under the Federal Food, Drug, and Cosmetic Act | 122 | |
Use of Alcohol in Pharmacy Practice | 123 | |
Poison Prevention Packaging Act | 123 | |
Drug Advertising by Pharmacies | 126 | |
Case Studies | 129 | |
Chapter 4 | The Closed System of Controlled Substance Distribution | 145 |
Chapter Objectives | 145 | |
State Versus Federal Authority | 146 | |
Classification of Controlled Substances | 147 | |
Authority for Scheduling | 149 | |
Manufacturer Labeling and Packaging | 150 | |
Registration | 150 | |
Security Requirements | 158 | |
Penalties | 159 | |
Pharmacy Inspections | 161 | |
Opioid Treatment Programs | 166 | |
Laws Related to the Controlled Substances Act | 168 | |
Case Studies | 170 | |
Chapter 5 | Dispensing Controlled Substances | 185 |
Chapter Objectives | 185 | |
Prescriptions | 185 | |
Recordkeeping | 200 | |
Drug Enforcement Administration Order Form 222 | 206 | |
Case Studies | 211 | |
Chapter 6 | Federal Regulation of Pharmacy Practice | 227 |
Chapter Objectives | 227 | |
The Omnibus Budget Reconciliation Act of 1990 | 227 | |
Health Insurance Portability and Accountability Act of 1996 | 233 | |
Medicare | 240 | |
Medicaid | 243 | |
Medicare/Medicaid Fraud and Abuse Statute | 246 | |
Federal Regulation of Long-Term Care | 248 | |
Federal Antitrust Laws | 251 | |
Case Studies | 261 | |
Chapter 7 | State Regulation of Pharmacy Practice | 275 |
Chapter Objectives | 275 | |
Self-Regulation in Pharmacy | 275 | |
A Different World | 276 | |
Approaches to Regulation | 277 | |
State Board of Pharmacy | 278 | |
Licensing | 279 | |
Actions Against a License | 281 | |
Actions Against a Pharmacy License | 284 | |
Standards of Practice | 285 | |
State Hospital Pharmacy Licensure Issues | 288 | |
State Regulation of Long-Term Care | 289 | |
State and Judicial Regulation of Third-Party Plans | 290 | |
Regulation for Outcomes | 293 | |
Case Studies | 295 | |
Chapter 8 | Pharmacist Malpractice Liability and Risk Management Strategies | 313 |
Chapter Objectives | 313 | |
Legal Procedure | 314 | |
The Malpractice Action | 314 | |
Liability for Failure to Perform Expanded Responsibilities | 323 | |
Risk Management Strategies | 330 | |
The Pharmacist as Risk Manager | 334 | |
Malpractice Insurance | 337 | |
Drug Product Liability | 337 | |
Case Studies | 345 | |
Table of Cases | 365 | |
Index | 371 |
From the B&N Reads Blog
Page 1 of